Outside of easy display of chronic obstructive pulmonary disease: clinical and functional-morphological aspects of changes of intestines
https://doi.org/10.20538/1682-0363-2009-4(2)-17-26
Abstract
At patients chronic obstructive pulmonary disease (COPD) average degree of gravity and heavy stages decrease absorption functions of a thin gut is established concerning fats, protein, carbohydrates, progressing with weight of disease, a degree of degenerate-dystrophic changes of a mucous membrane of a thin gut with its infringement regeneration potentialities. The received data are interpreted in a context of interrelation of function, structure of a mucous thin gut and a clinical component. Direct correlation communications between deficiency of weight of a body of patients COPD and decrease absorption functions of a thin gut in the attitude are established albuminum (r = 0,71), fats (r = 0,55), carbohydrates (r = 0,48).
About the Authors
E. I. Beloborodova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
L. A. Akimova
Томский военно-медицинский институт
Russian Federation
Russian Federation
N. G. Kritskaya
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
A. V. Asanova
Городская больница № 3
Russian Federation
Russian Federation
Ye. V. Semenenko
Городская больница № 3
Russian Federation
Russian Federation
References
1. Беленькая Т.Ю. Проба с D-ксилозой в оценке функции кишечника//Ученые зап. мед. науки. Петрозаводский ун-т, 1970. Т. 17, № 5. С. 78-81.
2. Гельцер Б.И., Кочеткова Е.А., Невзорова Е.А. и др. Хронические обструктивные болезни легких и остеопороз//Терап. арх. 2000. № 11. С. 74-77.
3. Задионченко В.С., Гринева З.О., Погонченкова И.В., Свиридов А.А. Нарушения ритма сердца у больных хроническими обструктивными болезнями легких//Пульмонология. 2003. № 6. С. 88-92.
4. Ишмухаметов Л.И. Радиоизотопная диагностика заболеваний органов пищеварения. М.: Медицина, 1979.
5. Физиология всасывания. В серии «Руководство по физиологии»/под ред. А.М. Уголева, Н.Ш. Амирова, Р.О., Файтельберг и др. Л.: Наука, 1977.
6. Физиология пищеварения. В серии «Руководство по физиологии»/под ред. А.В. Соловьёва, П.Г. Богач, Е.М. Матросова, А.М. Уголева и др. Л.: Наука, 1974.
7. Agusti A.G.N. Systemic effects of chronic obstructive pulmonary disease//Proc. Am. Thorac. Soc. 2005. № 2. P. 367-370.
8. Agusti A.G.N., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease//Eur. Respir. J. 2003. V. 21, № 2. P. 347-360.
9. Agusti A.G.N., Sauleda J., Miralles C. et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 2002. V. 166. P. 485-489.
10. Barnes P.J. Mediators of chronic obstructive pulmonary disease//Pharmacol. Rev. 2004. V. 56, № 4. P. 515-548.
11. Bolon C.E., Ionescu A.A., Shiels K.M. et al. Associated loss of fat free mass and bone mineral density in chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 2004. V. 170. P. 1286-1293.
12. Broekhuizen R., Grimbl R.F., Howell W.M. et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1(beta)-511 single nucleotide polymorphism//Am. J. Clin. Nutr. 2005. V. 82, № 5. P. 1059-1064.
13. Celli B.R., Cote C.C., Marin J.M. et al. The body-mass, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease//N. Engl. J. Med. 2004. V. 350, № 10. P. 1005-1012.
14. Debigare R., Cote C.H., Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms//Am. J. Respir. Crit. Care Med. 2002. V. 166. P. 485-489.
15. Di Francia M., Barbier D., Mege J.L., Orehek J. Tumor necrosis factor-a levels and weight loss in chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 1994. V. 150. P. 1453-1455.
16. Engelen M.P., Schols A.M., Baken W.C. et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD//Eur. Respir. J. 1994. V. 7. P. 1793-1797.
17. Faggiano P. Abnormalities of pulmonary function in congestive heart failure//Int. J. Cardiol. 1994. V. 44, № 1. P. 1-8.
18. Fourman L.P.R. Absorption of xylose in steatorrhea//Clin. Sc. 1948. V. 6, № 4. P. 289-294.
19. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. The association between chronic obstructive pulmonary disease and systemic inflammation a systematic review and a meta-analysis//Thorax 2004. V. 59. P. 574-580.
20. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention ofchronic obstructive pulmonary desease. NHLBI/WHO workshop report. Last updated 2006. www.goldcopd.org/.
21. Gosker H.R., Wouters E.F.M., Van der Vusse G.L., Schols A.M.W.J. Skeletal muscle dysfunction in COPD and chronic heart failure: underlying mechanisms and therapy perspectives//Am. J. Clin. Nutr. 2000. V. 71. P. 1033-1047.
22. Gray-Donald K., Gibbons L., Shapiro S.H. et al. Nutritional status and mortality in chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 1996. V. 153. P. 961-966.
23. Hunter A.M., Carey M.A., Larsh H.W. The nutritional status of patients with chronic obstructive pulmonary disease//Am. Rev. Respir. Dis. 1981. V. 124. P. 376-381.
24. Ionescu A.A., Schoon E. Osteoporosis in chronic obstructive pulmonary disease//Eur. Respir. J. 2003. V. 22. P. 64-75.
25. Kaplan E. and P. Meier. Nonparametric estimation from incomplete observations//J. Am. Stat. Assoc. 1958. V. 53. P. 457-481.
26. Landbo C., Prescott E., Lange P. et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 1999. V. 160. P. 1856-1861.
27. Langen R.S., Korn S.H. and Wouters E.F. ROS in the local and systemic pathogenesis of COPD//Free Radic. Biol. Med. 2003. V. 35, № 2. P.226-235.
28. Nishimura Y., Tsutsumi M., Nakata H. et al. Relationship between respiratory muscle strength and lean body mass in men with COPD//Chest.1995. V. 107. P. 1232-1236.
29. Petrache I., Otterbein L.E., Alam J. et al. Heme oxygenase -I inhibis TNF-a -induced apoptosis in cultured fibroblasts//Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. V. 278. P. 312-319.
30. Prescott E., Almdal T., Mikkelsen K.L. et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study//Eur. Respir. J. 2002. V. 20. P. 539-544.
31. Roe J.H., Rice E.W. A Photometric method for the determination of free pentoses animal fissues//Biol. Chem. 1948. V. 173, № 2. P. 507-512.
32. Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease//Am. J. Respir. Crit. Care Med. 1998. V. 157. P. 1791-1797.
33. Schols A.M.W.J., Soeters P.B., Dingemans A.M.C. et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation//Am. Rev. Respir. Dis. 1993. V. 147. P. 1151-1156.
34. Shoup R., Dalsky G., Warner S. et al. Body composition and health-related quality of life in patients with obstructive airways disease//Eur. Respir. J. 1997. V. 10. P. 1576-1580.
35. Wagner P.D. Possible mechanisms underlying the development of cachexia in COPD//Eur. Respir. J. 2008. V. 31. P. 492-501.
36. Wilson D.O., Rogers R.M., Wright E., Anthonisen N.R. Body weight in chronic obstructive pulmonary disease//Am. Rev. Respir. Dis. 1989. V. 139. Р. 1435-1438.
37. Wouters E.F. Chronic obstructive pulmonary disease, 5: systemic effects of COPD//Thorax. 2002. V. 57. P. 1067-1070.
38. Wouters E.F. Nutrition and metabolism in COPD//Chest. 2000. V. 117. P. 274-280.
Review
For citations:
Beloborodova E.I., Akimova L.A., Kritskaya N.G., Asanova A.V., Semenenko Ye.V. Outside of easy display of chronic obstructive pulmonary disease: clinical and functional-morphological aspects of changes of intestines. Bulletin of Siberian Medicine. 2009;8(4(2)):17-26. (In Russ.) https://doi.org/10.20538/1682-0363-2009-4(2)-17-26
Views:
1411
Email this article 